Zusammenfassung
Der systemische Lupus erythemathodes (SLE) ist eine B-Zell-vermittelte, chronisch-entzündliche Autoimmunkrankheit, die gekennzeichnet ist durch Produktion von Autoantikörpern gegen Zellkernbestandteile und Ablagerung von Immunkomplexen, die eine Vaskulitis verursachen. Zahlreiche Organe können betroffen sein, z. B. Haut, Niere, Lunge und ZNS. Die frühe Manifestation eines SLE ist häufig mit einem schweren Verlauf assoziiert. Zu den hier besprochenen seltenen rheumatischen Erkrankungen gehören mixed connective tissue disease, Sjögren-Syndrom und eosinophile Fasziitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Weiterführende Literatur
Bader-Meunier B, Armengaud JB, Haddad E et al (2005) Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 146:648–653
Chan TM, Tse KC, Tang CS et al (2005) Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16:1076–1084
Choi JH, Park DJ, Kang JH et al (2015) Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. Lupus 24:1342–1349
Contreras G, Pardo V, Leclercq et al (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350:971–980
Groot N, de Graeff N, Avcin T et al (2017a) European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis 76:1788–1796
Groot N, de Graeff N, Marks SD et al (2017b) European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis 76:1965–1973
Lehman TJA, Onel K (2000) Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 136:243–247
Lehman TJA, Edelheit BS, Onel KB (2004) Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Ann Rheum Dis 63:321–323
Lim LSH, Pullenayegum E, Lim L et al (2017) From childhood to adulthood: the trajectory of damage in patients with juvenile-onset systemic lupus erythematosus. Arthritis Care Res 69:1627–1635
Mahmoud I, Jellouli M, Boukhris I et al (2017) Efficacy and safety of rituximab in the management of pediatric systemic lupus erythematosus: a systematic review. J Pediatr 187:213–219
Mina R, Brunner H (2010) Pediatric lupus – are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin North Am 36:53–80, vii–viii
Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686
Petty RE, Laxer RM (2015) Textbook of pediatric rheumatology, 7. Aufl. Elsevier, Philadelphia
Shinjo SK, Bonfá E, Wojdyla D et al (2010) Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis Rheumatol 62:855–862
Tian SY, Silverman ED, Pullenayegum E et al (2017) Comparative effectiveness of mycophenolate mofetil for the treatment of juvenile-onset proliferative Lupus Nephritis. Arthritis Care Res 69:1887–1894
Tsokos GC (2011) Mechanism of disease: systemic lupus erythematosus. N Engl J Med 365:2110–2121
Wakeland EK, Liu K, Graham RR et al (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397–408
Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Wagner, N., Dannecker, G. (2020). Systemischer Lupus erythematodes und seltene rheumatische Krankheiten. In: Hoffmann, G.F., Lentze, M.J., Spranger, J., Zepp, F., Berner, R. (eds) Pädiatrie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60300-0_106
Download citation
DOI: https://doi.org/10.1007/978-3-662-60300-0_106
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-60299-7
Online ISBN: 978-3-662-60300-0
eBook Packages: Medicine (German Language)